JGC
OPTN

J. Goldman & Co’s OptiNose OPTN Stock Holding History

J. Goldman & Co’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-45,000
Closed -$452K – 579
2024
Q3 		$452K Buy
+45,000
New +$656K 0.01% 356

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

J. Goldman & Co's OPTN Position: Q4 2024 in Review

J. Goldman & Co sold out of OptiNose (OPTN) in Q4 2024, closing a stake of 45,000 shares — an estimated $452K sold.

J. Goldman & Co first reported a position in OPTN in Q3 2024 and held it in 1 quarter. The position peaked at $452K in Q3 2024. 40 funds tracked by Wall St. Rank hold OPTN as of Q4 2024.

  • J. Goldman & Co reported no remaining OptiNose position as of Q4 2024 after selling out during the quarter.
  • J. Goldman & Co sold 45,000 OptiNose shares in Q4 2024, an estimated $452K.
  • J. Goldman & Co first reported a position in OptiNose in Q3 2024 and held it in 1 quarter.
  • J. Goldman & Co's OptiNose position peaked at $452K in Q3 2024.
  • 40 funds tracked by Wall St. Rank held OptiNose as of Q4 2024.

Based on J. Goldman & Co's 13F filing for Q4 2024, filed 14 Feb 2025.